Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants - Project

Ma, Hongshen (The University of British Columbia)

$467,450.00

Microfluidic point-of-care immunoassay

EF 2017-18 · 2017-09-20

Résumé
Point-of-care tests are medical diagnostic tests performed outside of clinical laboratories and in close proximity of patients receiving care, such as at homes, doctor's offices, and emergency departments in hospitals. The ability to perform diagnostic tests without requiring sophisticated laboratory equipment and infrastructure is important for many health conditions including cancer, heart disease, and viral infections. This proposal aims to develop a new technology to perform point-of-care diagnostic tests utilizing methods developed for manufacturing silicon microchips, which can be adapted to enable precise control over the flow of extremely small volumes of liquid. This capability enables sophisticated biochemical analyses to be performed in portable, low-cost, and automated system, which can be utilized by patients and care providers at the point of care.
Programme
Collaborative Research and Development Grants - Project
Emplacement
British Columbia|Colombie-Britannique, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
Proactive Disclosure - Grants and Contributions

Tel que publié

Additional Information
Grant or Award spanning more than one fiscal year (2017-2018 to 2020-2021).
Additional Information (French)
Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier (2017-2018 à 2020-2021).
Agreement Number
CRDPJ
Agreement Start Date
2017-09-20
Agreement Title
Microfluidic point-of-care immunoassay
Agreement Title (French)
Microfluidic point-of-care immunoassay
Agreement Type
Grant
Agreement Value
$467,450.00
Amendment Number
0
Organization Code
nserc-crsng
Organization
Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada
Program Name
Collaborative Research and Development Grants - Project
Program Name (French)
Subventions de recherche et développement coopérative - projet
Program Purpose
Point-of-care tests are medical diagnostic tests performed outside of clinical laboratories and in close proximity of patients receiving care, such as at homes, doctor's offices, and emergency departments in hospitals. The ability to perform diagnostic tests without requiring sophisticated laboratory equipment and infrastructure is important for many health conditions including cancer, heart disease, and viral infections. This proposal aims to develop a new technology to perform point-of-care diagnostic tests utilizing methods developed for manufacturing silicon microchips, which can be adapted to enable precise control over the flow of extremely small volumes of liquid. This capability enables sophisticated biochemical analyses to be performed in portable, low-cost, and automated system, which can be utilized by patients and care providers at the point of care.
Program Purpose (French)
Point-of-care tests are medical diagnostic tests performed outside of clinical laboratories and in close proximity of patients receiving care, such as at homes, doctor's offices, and emergency departments in hospitals. The ability to perform diagnostic tests without requiring sophisticated laboratory equipment and infrastructure is important for many health conditions including cancer, heart disease, and viral infections. This proposal aims to develop a new technology to perform point-of-care diagnostic tests utilizing methods developed for manufacturing silicon microchips, which can be adapted to enable precise control over the flow of extremely small volumes of liquid. This capability enables sophisticated biochemical analyses to be performed in portable, low-cost, and automated system, which can be utilized by patients and care providers at the point of care.
Recipient City
British Columbia|Colombie-Britannique
Recipient Country
CA
Recipient Legal Name
Ma, Hongshen (The University of British Columbia)
Reference Number
GC-2017-Q2-04360